What happens if I choose no treatment for Ovarian Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding the "Watch and Wait" Approach for Ovarian Cancer
This is an important question, and I appreciate you asking it directly. Let me explain what the medical evidence shows about choosing no treatment, while being clear about the different scenarios where this decision might apply.
The Clinical Context: When "No Treatment" Might Be Considered
First, it's important to understand that "no treatment" in ovarian cancer is not a simple yes/no decision. The approach depends heavily on:
- Your cancer stage (early vs. advanced)
- Your specific diagnosis (type of ovarian cancer)
- Your tumor burden (how much cancer is present)
- Your overall health and preferences
According to the NCCN (National Comprehensive Cancer Network) Guidelines for ovarian cancer, treatment decisions are individualized based on these factors.
What Generally Happens Without Treatment
In early-stage ovarian cancer:
- Without treatment, most early-stage cancers will eventually progress (grow and spread)
- The timeline varies significantly—some grow slowly, others more rapidly
- Once progression occurs, treatment becomes more complex and outcomes are typically less favorable than if treated earlier
In advanced ovarian cancer:
- Without treatment, cancer typically continues to grow
- Symptoms often worsen over time (pain, abdominal swelling, fatigue, digestive problems)
- The cancer may spread to additional organs
- Life expectancy is generally shortened compared to patients receiving treatment
The "Adaptive Therapy" or Monitoring Approach
Interestingly, one of the webinars in the medical literature discusses an emerging concept called adaptive therapy for ovarian cancer. According to Dr. [removed] Gatenby's work on evolutionary treatment strategies, researchers in the UK (Dr. [removed] Lockley) have started a trial in ovarian cancer using an approach where the goal is to:
- Keep the tumor stable in size rather than trying to eliminate it completely
- Continuously adjust drug doses to maintain stability
- Potentially use less medication over time while maintaining control
This is different from "no treatment"—it's strategic, monitored treatment designed to maintain quality of life while controlling disease. This approach is still investigational and not standard care.
Important Distinctions
"No treatment" is different from:
- Surveillance/monitoring - Regular imaging and blood tests to watch for changes
- Adaptive therapy - Strategic, adjusted treatment to maintain stability
- Palliative care - Comfort-focused care that can be combined with other treatments
Questions to Ask Your Oncologist
If you're considering delaying or avoiding treatment, these questions are essential:
- "What is my specific cancer stage and type?" (This determines urgency)
- "What would happen if we monitored my cancer with regular scans instead of treating immediately?" (Is this medically appropriate for my situation?)
- "Are there clinical trials available, such as adaptive therapy approaches?" (Emerging options may exist)
- "What symptoms should I watch for that would indicate I need to start treatment?"
- "How frequently would we need to monitor with imaging and blood tests?"
- "What are the risks of waiting versus treating now?"
- "Are there treatment options that might have fewer side effects than standard chemotherapy?" (PARP inhibitors, targeted therapies, or other options depending on your biomarkers)
The Reality of Ovarian Cancer
According to the medical literature and NCCN Guidelines, ovarian cancer is generally considered a disease that benefits from treatment when diagnosed. However, the type and timing of treatment can be personalized based on:
- Your tumor's genetic characteristics (BRCA status, other mutations)
- Your overall health
- Your values and quality-of-life priorities
- Whether your cancer is newly diagnosed or recurrent
A Balanced Perspective
The webinar discussions emphasize that patients should have agency in their care decisions. This means:
✅ You have the right to understand your options fully ✅ You can discuss concerns about side effects ✅ You can explore less aggressive approaches if appropriate for your stage ✅ You deserve shared decision-making with your team
❌ But "no treatment" for most ovarian cancers typically leads to disease progression
Next Steps
Rather than choosing "no treatment," I'd encourage you to:
- Get a clear understanding of your specific diagnosis - stage, type, biomarkers
- Discuss all options - standard treatment, clinical trials, adaptive approaches, monitoring strategies
- Express your concerns - about side effects, quality of life, treatment burden
- Ask about personalized approaches - your cancer may have specific characteristics that open up targeted options
Your oncologist can help determine whether monitoring, adaptive therapy, or standard treatment is most appropriate for YOUR specific situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Ovarian Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Ovarian Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
How do I manage pain from advanced ovarian cancer
Pain management is an important part of your overall care with advanced ovarian cancer. Let me explain the approaches your healthcare team typically u
What are the treatment options for advanced metastatic ovarian cancer
Advanced metastatic ovarian cancer—where the cancer has spread beyond the ovaries—is treated with a combination approach. Let me walk you through how